Health
Inhaled steroid ciclesonide suppresses SARS-CoV-2 replication in vitro – News-Medical.Net
A new paper by researchers at Japan’s National Institute of Infectious Diseases and published on the preprint server bioRxiv in August 2020 reports the in vitro suppression of coronavirus (CoV) replication by an inhaled corticosteroid (ICS) ciclesonide.
With the COVID-19 pandemic, the world has suffered hundreds of thousands of deaths and tens of millions of cases. In order to contain this outbreak, new and already approved drugs are being tested. A new paper by researchers at Japan’s National Institute of Infectious Diseases and published on the preprint server bioRxiv* in August 2020 reports the in vitro suppression of coronavirus (CoV) replication by an inhaled corticosteroid (ICS) ciclesonide.
Steroids have been repurposed for the treatmen…
-
General23 hours agoSuper Typhoon Ragasa lashes Taiwan, with two dead and 30 missing
-
Business19 hours agoHow to spot the next WiseTech or Pro Medicus on the ASX
-
General21 hours agoRussia systematically torturing Ukrainian civilians, UN says
-
General19 hours agoLegal fights are brewing over which online social platforms will have to ban under-16s